These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7129032

  • 1. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
    Chase WF, Winn RE, Mayes GR.
    Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
    [Abstract] [Full Text] [Related]

  • 2. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL, Czaja AJ, Ludwig J.
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP, Lepiorz H, Berthold H, Gerok W.
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [Abstract] [Full Text] [Related]

  • 4. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G, Ruggiero G, Galanti B, Piccinino F, Russo M, Galante D, Sagnelli E, Utili R, Pasquale G, Nardiello S, Aloisio V.
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [Abstract] [Full Text] [Related]

  • 5. Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
    De Virgiliis S, Argiolu F, Rais M, Cossu P, Toccafondi C, Sanna G, Cornacchia G, Nucaro A, Bertolino F, Ferreli A.
    Helv Paediatr Acta; 1983 Aug; 38(3):255-65. PubMed ID: 6618892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The immune compartment in chronic active liver disease responsive and non-responsive to corticoid therapy].
    Buligescu L, Mateescu-Cutcudache O, Mihai E.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987 Aug; 39(1):91-5. PubMed ID: 2884716
    [No Abstract] [Full Text] [Related]

  • 8. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB.
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
    Giusti G, Piccinino F, Galanti B, Sagnelli E, Ruggiero G, Gallo C.
    Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
    [Abstract] [Full Text] [Related]

  • 10. [T-lymphocyte subpopulations in chronic active hepatitis].
    Fucíková T, Brodanová M, Bartůnková J, Skopový P, Hausner P, Krupicka J.
    Sb Lek; 1991 Mar; 93(1-2):27-32. PubMed ID: 2047739
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Mar; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
    Romeo F, Arcoria D, Palmisano L, Polosa P.
    Arzneimittelforschung; 1985 Mar; 35(8):1317-22. PubMed ID: 3907642
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influencing immune perturbations by prolonged corticotherapy in the chronic active liver disease.
    Banciu T, Arcan P, Stroe A.
    Med Interne; 1985 Mar; 23(3):177-83. PubMed ID: 4048798
    [Abstract] [Full Text] [Related]

  • 17. Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis.
    Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C.
    Liver; 1985 Feb; 5(1):8-12. PubMed ID: 3884951
    [Abstract] [Full Text] [Related]

  • 18. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
    Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B.
    Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.